- Home
- DVLT vs ALGS Comparison
DVLT vs ALGS Comparison
Compare DVLT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVLT
- ALGS
- Stock Information
- Founded
- DVLT 2010
- ALGS 2018
- Country
- DVLT United States
- ALGS United States
- Employees
- DVLT N/A
- ALGS N/A
- Industry
- DVLT
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- DVLT
- ALGS Health Care
- Exchange
- DVLT NYSE
- ALGS Nasdaq
- Market Cap
- DVLT 55.7M
- ALGS 50.4M
- IPO Year
- DVLT N/A
- ALGS 2020
- Fundamental
- Price
- DVLT $0.71
- ALGS $8.46
- Analyst Decision
- DVLT Strong Buy
- ALGS Strong Buy
- Analyst Count
- DVLT 1
- ALGS 1
- Target Price
- DVLT $3.00
- ALGS $70.00
- AVG Volume (30 Days)
- DVLT 563.6K
- ALGS 99.2K
- Earning Date
- DVLT 08-13-2025
- ALGS 08-05-2025
- Dividend Yield
- DVLT N/A
- ALGS N/A
- EPS Growth
- DVLT N/A
- ALGS N/A
- EPS
- DVLT N/A
- ALGS N/A
- Revenue
- DVLT $3,048,000.00
- ALGS $3,270,000.00
- Revenue This Year
- DVLT $434.03
- ALGS N/A
- Revenue Next Year
- DVLT $221.43
- ALGS $51.55
- P/E Ratio
- DVLT N/A
- ALGS N/A
- Revenue Growth
- DVLT 63.08
- ALGS N/A
- 52 Week Low
- DVLT $0.60
- ALGS $3.76
- 52 Week High
- DVLT $3.25
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- DVLT N/A
- ALGS 63.36
- Support Level
- DVLT N/A
- ALGS $6.82
- Resistance Level
- DVLT N/A
- ALGS $9.10
- Average True Range (ATR)
- DVLT 0.00
- ALGS 0.75
- MACD
- DVLT 0.00
- ALGS 0.08
- Stochastic Oscillator
- DVLT 0.00
- ALGS 86.38
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.